Mutations in the katG gene can significantly impact the effectiveness of antibiotic treatment. For instance, a common mutation at codon 315 (S315T) in the katG gene results in reduced catalase-peroxidase activity. This mutation is frequently associated with isoniazid resistance, posing a major challenge in the management of tuberculosis.
